111 related articles for article (PubMed ID: 3124554)
1. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat.
Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K
Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554
[TBL] [Abstract][Full Text] [Related]
2. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
3. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
Shibouta Y; Terashita Z; Inada Y; Nishikawa K
Eur J Pharmacol; 1985 Feb; 109(2):135-44. PubMed ID: 3922775
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
Stier CT; Itskovitz HD
Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats.
Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S
Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of pinane-thromboxane A2 and indomethacin in saline volume-expanded spontaneously hypertensive rats.
Shibouta Y; Terashita ZI; Inada Y; Kato K; Nishikawa K
Eur J Pharmacol; 1982 Nov; 85(1):51-9. PubMed ID: 7151863
[TBL] [Abstract][Full Text] [Related]
7. Role of prostaglandin I2 and thromboxane A2 in recurring reduction of carotid and cerebral blood flow in dogs.
Uchida Y; Murao S
Stroke; 1981; 12(6):786-92. PubMed ID: 7029792
[TBL] [Abstract][Full Text] [Related]
8. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat].
Nakayama D; Ikeda T
Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014
[No Abstract] [Full Text] [Related]
9. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
Lianos EA; Andres GA; Dunn MJ
J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypotensive effect of the thromboxane A2/prostaglandin H2 receptor antagonist S-1452 in spontaneously hypertensive rats.
Sugimoto KI; Shiga T; Fujimura A
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):594-600. PubMed ID: 10901388
[TBL] [Abstract][Full Text] [Related]
11. Prostanoids and aldosterone-induced mild experimental hypertension in rats.
Hui RT; Grose JH; Lebel M; Falardeau P
Hypertension; 1990 Feb; 15(2):198-203. PubMed ID: 2303282
[TBL] [Abstract][Full Text] [Related]
12. 1-Benzylimidazole, a thromboxane synthetase inhibitor acutely lowers blood pressure mainly by alpha-adrenoceptor blockade in spontaneously hypertensive rats (SHR).
Lucas J; Chan PS; Mateja N; Cervoni P; Ronsberg MA; Lipchuck LM
Prostaglandins Leukot Med; 1983 Dec; 12(4):409-21. PubMed ID: 6142461
[TBL] [Abstract][Full Text] [Related]
13. Involvement of prostaglandins and renal haemodynamics in salt-sensitivity of young spontaneously hypertensive rats.
Ando K; Ono A; Sato Y; Fujita T
J Hypertens; 1993 Apr; 11(4):373-7. PubMed ID: 8390504
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
Stork JE; Dunn MJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
[TBL] [Abstract][Full Text] [Related]
15. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure effects of thromboxane A2 blockade in spontaneously hypertensive rats.
Boussairi EH; Sacquet J; Benzoni D; Sassard J
Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):679-87. PubMed ID: 8306513
[TBL] [Abstract][Full Text] [Related]
17. No evidence on significant roles of the prostaglandin-thromboxane and kallikrein-kinin system in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin.
Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
Clin Exp Hypertens A; 1987; 9(2-3):323-8. PubMed ID: 2440625
[TBL] [Abstract][Full Text] [Related]
18. Oxygen-derived free radical-induced vasoconstriction by thromboxane A2 in aorta of the spontaneously hypertensive rat.
Hibino M; Okumura K; Iwama Y; Mokuno S; Osanai H; Matsui H; Toki Y; Ito T
J Cardiovasc Pharmacol; 1999 Apr; 33(4):605-10. PubMed ID: 10218731
[TBL] [Abstract][Full Text] [Related]
19. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.
Xavier FE; Davel AP; Fukuda LE; Rossoni LV
J Hypertens; 2009 Jun; 27(6):1233-42. PubMed ID: 19337130
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.
Huang A; Sun D; Koller A
Hypertension; 1993 Dec; 22(6):913-21. PubMed ID: 8244524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
